Ancora Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $83.6K | Buy |
1,196
+47
| +4% | +$3.28K | ﹤0.01% | 901 |
|
2025
Q1 | $84.5K | Sell |
1,149
-50
| -4% | -$3.68K | ﹤0.01% | 888 |
|
2024
Q4 | $78.6K | Buy |
1,199
+50
| +4% | +$3.28K | ﹤0.01% | 890 |
|
2024
Q3 | $89.5K | Hold |
1,149
| – | – | ﹤0.01% | 837 |
|
2024
Q2 | $89.6K | Sell |
1,149
-585
| -34% | -$45.6K | ﹤0.01% | 793 |
|
2024
Q1 | $117K | Buy |
1,734
+4
| +0.2% | +$271 | ﹤0.01% | 761 |
|
2023
Q4 | $117K | Hold |
1,730
| – | – | ﹤0.01% | 750 |
|
2023
Q3 | $117K | Sell |
1,730
-121
| -7% | -$8.2K | ﹤0.01% | 737 |
|
2023
Q2 | $132K | Buy |
1,851
+22
| +1% | +$1.57K | ﹤0.01% | 715 |
|
2023
Q1 | $127K | Buy |
1,829
+103
| +6% | +$7.15K | ﹤0.01% | 715 |
|
2022
Q4 | $117K | Sell |
1,726
-300
| -15% | -$20.3K | ﹤0.01% | 765 |
|
2022
Q3 | $111K | Buy |
2,026
+217
| +12% | +$11.9K | ﹤0.01% | 840 |
|
2022
Q2 | $120K | Sell |
1,809
-387
| -18% | -$25.7K | ﹤0.01% | 879 |
|
2022
Q1 | $146K | Hold |
2,196
| – | – | ﹤0.01% | 885 |
|
2021
Q4 | $128K | Hold |
2,196
| – | – | ﹤0.01% | 940 |
|
2021
Q3 | $132K | Sell |
2,196
-104
| -5% | -$6.25K | ﹤0.01% | 884 |
|
2021
Q2 | $138K | Hold |
2,300
| – | – | ﹤0.01% | 822 |
|
2021
Q1 | $114K | Buy |
2,300
+104
| +5% | +$5.16K | ﹤0.01% | 826 |
|
2020
Q4 | $110K | Sell |
2,196
-1,938
| -47% | -$97.1K | ﹤0.01% | 718 |
|
2020
Q3 | $227K | Buy |
4,134
+1,309
| +46% | +$71.9K | 0.01% | 566 |
|
2020
Q2 | $149K | Buy |
2,825
+687
| +32% | +$36.2K | 0.01% | 621 |
|
2020
Q1 | $95K | Hold |
2,138
| – | – | ﹤0.01% | 758 |
|
2019
Q4 | $107K | Buy |
+2,138
| New | +$107K | ﹤0.01% | 751 |
|
2018
Q4 | – | Sell |
-2,138
| Closed | -$85K | – | 653 |
|
2018
Q3 | $85K | Buy |
+2,138
| New | +$85K | ﹤0.01% | 791 |
|
2017
Q1 | – | Sell |
-604
| Closed | -$16K | – | 644 |
|
2016
Q4 | $16K | Buy |
+604
| New | +$16K | ﹤0.01% | 978 |
|